Catheter, Hemodialysis, Triple Lumen, Non-implanted

Device Code: 2018

Product Code(s): NIE

Definition: Short-term (< 30 Days) Central Venous Access For Hemodialysis And Apheresis, With A Third Lumen For Infusion.

Device Classification Information

Device Type ID2018
Device NameCatheter, Hemodialysis, Triple Lumen, Non-implanted
Regulation DescriptionBlood Access Device And Accessories.
Regulation Medical SpecialtyGastroenterology/Urology
Review PanelGastroenterology/Urology
Premarket Review Office Of Device Evaluation (ODE)
Division Of Reproductive, Gastro-Renal, And Urological Devices (DRGUD)
Renal Devices Branch (RNDB)
Submission Type510(k)
CFR Regulation Number876.5540 [🔎]
FDA Device ClassificationClass 2 Medical Device
Product CodeNIE
GMP ExemptNo
Summary MREligible
Implanted DeviceNo
Life Support DeviceYes
Third Party Review Not Third Party Eligible

Recognized Standards

Total Product Life Cycle

Device Type ID2018
DeviceCatheter, Hemodialysis, Triple Lumen, Non-implanted
Product CodeNIE
FDA Device ClassificationClass 2 Medical Device
Regulation DescriptionBlood Access Device And Accessories.
CFR Regulation Number876.5540 [🔎]
Premarket Reviews
ManufacturerDecision
C.R. BARD, INC.
 
SUBSTANTIALLY EQUIVALENT - KIT WITH DRUGS
2
Device Problems
Break
10
Infusion Or Flow Problem
7
Difficult To Remove
6
Kinked
5
Deformation Due To Compressive Stress
3
Obstruction Of Flow
2
Material Frayed
2
Difficult To Advance
2
Device Damaged Prior To Use
1
Crack
1
Cut In Material
1
Split
1
Detachment Of Device Or Device Component
1
Leak / Splash
1
Material Deformation
1
Hole In Material
1
Occlusion Within Device
1
Material Puncture / Hole
1
Catheter
1
Device Operates Differently Than Expected
1
Human-Device Interface Problem
1
Migration Or Expulsion Of Device
1
Improper Or Incorrect Procedure Or Method
1
Total Device Problems 52
Recalls
Manufacturer Recall Class Date Posted
1
Arrow International Inc
II Apr-10-2018
TPLC Last Update: 2019-04-02 20:04:21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.